Oral Contraceptive/Folic Acid 400 Ug Combination Proposed By J&J
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's Ortho-McNeil Pharmaceuticals group is proposing to develop a product combining an oral contraceptive with 400 ug folic acid "to be used by women who elect to use OCs as a method of contraception and in whom supplemental folic acid intake is desirable.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning